Merck shares jump after combination trial shows Keytruda extends lung cancer survival

Jan 17, 2018 , CNBC Health
Merck's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer.

Read the full story...

Trending healthcare news keywords at this moment

cvs disease drug costs scripts deal work healthcare million cancer boost medicare plans drugs ebola exercise tied vaccine care study women heart tip kids patients diabetes brain hospital risk medical doctors people merger aid gene treatment fda teen asthma patient